Annenberg Center for Health Sciences
Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies
The treatment of persons with hemophilia continues to evolve, with important advancements that address limitations with factor replacement such as diminished efficacy in patients with inhibitors and the burden of frequent intravenous administration. This 30-minute activity delves into the latest research presented at ISTH 2025, highlighting rebalancing agents and factor VIII mimetics. In addition to discussing details of each trial, Dr. von Drygalski shares her thoughts about its importance and relevance to clinical practice.
Author
Annenberg Center for Health Sciences
Category
Podcast website
Latest episode
Aug 8, 2025
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Conclusions 08.08.2025 0:32
Dr. von Drygalski shares her thoughts about the importance of this research and its relevance to clinical practice.
Factor VIII Mimetics 01.08.2025 14:17
Abstract 4: Effectiveness of emicizumab in hemophilia A: A 4th interim analysis of the real-world study EMIIL Abstract 5: Prospective evaluation of a defined replacement protocol for peri-operative hemostasis in patients with severe hemophilia A with and without inhibitors on emicizumab prophylaxis undergoing elective major surgeries-final results. (EmiSurg Study) Abstract 6: FRONTIER5 direct swit...
A Focus on Rebalancing Agents 01.08.2025 10:39
Abstract 1: Association of antithrombin levels with efficacy of fitusiran prophylaxis in people with hemophilia A or B with and without inhibitors: a predictive modeling approach Abstract 2: Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 study Abstract 3: Long-term efficacy of marstacimab in participants with severe hemophilia A or B without inhibitors
Similar podcasts
Listen to the Perspectives on Selected Hemophilia Research Presented at ISTH 2025: Nonfactor Replacement Therapies podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
